UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity

Science translational medicine, 2014-11, Vol.6 (261), p.261ra151

2014

Volltextzugriff (PDF)

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)

PloS one, 2015-03, Vol.10 (3), p.e0121071-e0121071

2015

Volltextzugriff (PDF)

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2017-09, Vol.12 (9), p.1421-1433

2017

Volltextzugriff (PDF)

Iron addiction with ferroptosis-resistance in asbestos-induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention

Free radical biology & medicine, 2019-03, Vol.133, p.206-215

Toyokuni, Shinya

2019

Volltextzugriff (PDF)

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays

Human pathology, 2019-05, Vol.87, p.11-17

2019

Volltextzugriff (PDF)

A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis

Lung cancer (Amsterdam, Netherlands), 2018-11, Vol.125, p.198-204

2018

Volltextzugriff (PDF)

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma

Modern pathology, 2016-01, Vol.29 (1), p.14-24

2016

Volltextzugriff (PDF)

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

Annals of oncology, 2013-12, Vol.24 (12), p.3128-3135

2013

Volltextzugriff (PDF)

Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia

Redox biology, 2019-09, Vol.26, p.101297, Article 101297

2019

Volltextzugriff (PDF)

Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry

Lung cancer (Amsterdam, Netherlands), 2017-02, Vol.104, p.98-105

2017

Volltextzugriff (PDF)

Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis

Cancer letters, 2017-01, Vol.385, p.215-224

2017

Volltextzugriff (PDF)

Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas

Archives of pathology & laboratory medicine (1976), 2018-12, Vol.142 (12), p.1549-1553

2018

Volltextzugriff (PDF)

Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers

Clinical cancer research, 2019-08, Vol.25 (15), p.4723-4734

2019

Volltextzugriff (PDF)

Metabolic rewiring and redox alterations in malignant pleural mesothelioma

British journal of cancer, 2020-01, Vol.122 (1), p.52-61

2020

Volltextzugriff (PDF)

Intracavitary ‘T4 immunotherapy’ of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells

Cancer letters, 2017-05, Vol.393, p.52-59

2017

Volltextzugriff (PDF)

Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication

Cancer letters, 2019-10, Vol.463, p.27-36

2019

Volltextzugriff (PDF)

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma

Human pathology, 2015-11, Vol.46 (11), p.1670-1678

2015

Volltextzugriff (PDF)

NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma

International journal of molecular sciences, 2018-03, Vol.19 (4), p.988

2018

Volltextzugriff (PDF)

Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma

PloS one, 2014-09, Vol.9 (9), p.e106742-e106742

2014

Volltextzugriff (PDF)

Malignant mesothelioma as an oxidative stress-induced cancer: An update

Free radical biology & medicine, 2015-09, Vol.86, p.166-178

2015

Volltextzugriff (PDF)

Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study

Journal of thoracic oncology, 2015-03, Vol.10 (3), p.492-499

2015

Volltextzugriff (PDF)

Exosomal miR-16-5p as a target for malignant mesothelioma

Scientific reports, 2019-08, Vol.9 (1), p.11688-13, Article 11688

2019

Volltextzugriff (PDF)

BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas

Journal of thoracic oncology, 2017-04, Vol.12 (4), p.724-733

2017

Volltextzugriff (PDF)

Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma

International journal of molecular sciences, 2018-03, Vol.19 (4), p.1041

2018

Volltextzugriff (PDF)

1 – 25 von 585

Suche als RSS-Feed

Aktive Filter

ThemaMesothelioma, Malignant

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(534)
Mit Volltextzugriff
(534)

Publikationsform

Artikel
(585)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Oncotarget
(31)
International Journal Of Molecular Sciences
(24)
Plos One
(24)
Journal Of Thoracic Oncology
(23)
Lung Cancer
(20)
Scientific Reports
(16)
Anticancer Research
(11)
International Journal Of Oncology
(11)
Bmc Cancer
(10)
Cancer Science
(10)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Iron addiction with ferroptosis-resistance in asbestos-induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays

A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia

Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry

Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis

Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas

Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers

Metabolic rewiring and redox alterations in malignant pleural mesothelioma

Intracavitary ‘T4 immunotherapy’ of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells

Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma

NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma

Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma

Malignant mesothelioma as an oxidative stress-induced cancer: An update

Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study

Exosomal miR-16-5p as a target for malignant mesothelioma

BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas

Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma

Aktive Filter

Suchergebnisse filtern